[6].Sprague SM et al. Diagnosis Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. Am J Kidney Dis. 2016 Apr; 67(4):559-66. Epub 2015 Aug 25 [7].Bakkaloglu SA et al. Value of the new bone...
Evaluation,ClassificationandStratification.AmJKidDis39(suppl1):S1-S266,2002 ConceptualModelforCKD(revised)Levey,Stevens,CoreshAmJKidneyDis2009;53S3:S4-S16 ComplicationsComplications NormalNormal IncreasedIncreasedriskrisk DamageDamage ↓GFR↓GFR KidneyKidneyfailurefailure DeathDeath ...
Definition Chronic kidney disease (CKD) means any abnormality of the renal parenchyma that will not recover. A progressive decline in kidney function may occur, but only if both kidneys are abnormal. Classification Staging of CKD CKD is divided into stages according to its severity ( Table ...
The Kidney Disease Outcomes Quality Initiative (KDOQI) of the National Kidney Foundation (NKF) established a definition and classification of CKD in 2002. [4] The KDOQI and the international guideline group Kidney Disease: Improving Global Outcomes (KDIGO) subsequently updated these guidelines; the ...
1. Levey AS, Eckardt KW, Tsukamoto Q, Levin A, Coresh J, Rossert J, de Zeeuw D, Hostette TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International 2005;67:2089-10...
方法采用回顾性队列研究,选择2005年在上海市和北京市8家医院被确诊为PAD的841例患者作为研究对象,分别利用MDRD与CKD-EPI公式估算肾小球滤过率(eGFR),应用Spearman相关性检验、Bland-Altman曲线和Kappa检验比较两种方程估算GFR的相关性和一致性,并利用净重新分类指数(net re-classification improvement,NRI)比较2个公式对...
中国专家共识:噻唑烷二酮类在慢性肾脏病患者的应用CKD分期GFR药物1-2期≥603a期59-453b期44-304期29-155期15吡格列酮可导致多种不良反应1:心衰,骨折,膀胱癌2010年,罗格列酮被欧洲药监局、美国食品药物管理局及中国药监部门勒令禁止或限制在2型糖尿病的患者中使用吡格列酮:GFR≥45,无需调整剂量GFR45,证据有限...
GFRGFR ••CRFCRF CKD(美国KDOQI) 分期特征GFR水平(ml/min) 0CKD危险增加>90,有CKD危险因素 1已有肾病GFR正常9090 2GFR轻度降低60-89 3GFR中度降低30-59 4GFR重度降低15-29 5ESRD(肾衰竭)<15 *KDOQI:Kidneydiseasesoutcomequalityinitiative CKD ...
伴或不伴GFR下降，表现为肾病理异常或反映肾损害的实验室检查异常（血，尿或影像学）。•CKD：发现肾脏功能或结构损害>=3个月，•CRF：慢性肾病所引起的肾组织损伤和肾小球滤过率下降，以及由此产生的代谢紊乱和临床症状组成的综合征。CKD分期方法的建议(美国KDOQI)分期特征0CKD危险增加1已有肾病GFR正常GFR水平（...
早期 防治基础病防治多因素干预-综合防治个体化治疗结语CKD -CRF 定义CKD :发现肾脏功能或结构损害=3个月,伴或不伴GFR下降,表现为肾病理异常或反映肾损害的实验室检查异常(血,尿或影像学)。 CRF:慢性肾病所引起的肾组织损伤和肾小球滤过率下降,以及由此产生的代谢紊乱和临床症状组成的综合征。CKD分期方法的建议(...